Sabra Health Care REIT, Inc. (SBRA)

Stock Price Forecast

The 7 analysts that cover Sabra Health Care REIT stock have a consensus rating of "Buy" and an average price target of $19.71, which forecasts a 7.88% increase in the stock price over the next year. The lowest target is $18 and the highest is $20.

Price Target: $19.71 (+7.88%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$18	$19.71	$20	$20
Change	-1.48%	+7.88%	+9.47%	+9.47%

Analyst Ratings

The average analyst rating for Sabra Health Care REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	2	1	1	1	1	1
Buy	2	3	3	3	3	3
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Nicholas Yulico Scotiabank	Scotiabank	Hold Maintains $19 → $20	Hold	Maintains	$19 → $20	+9.47%	Jun 23, 2025
Nicholas Yulico Scotiabank	Scotiabank	Hold Maintains $18 → $19	Hold	Maintains	$18 → $19	+4.00%	May 12, 2025
Michael Lewis Truist Securities	Truist Securities	Hold Maintains $17 → $18	Hold	Maintains	$17 → $18	-1.48%	Mar 18, 2025
Matthew Carletti Citizens Capital Markets	Citizens Capital Markets	Buy Reiterates $20	Buy	Reiterates	$20	+9.47%	Feb 21, 2025
Michael Lewis Truist Securities	Truist Securities	Strong Buy → Hold Downgrades $18 → $17	Strong Buy → Hold	Downgrades	$18 → $17	-6.95%	Jan 17, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

744.15M

Increased by 5.91%

from 702.64M

Revenue Next Year

783.62M

Increased by 5.30%

from 744.15M

EPS This Year

0.72

Increased by 33.30%

from 0.54

EPS Next Year

0.79

Increased by 9.31%

from 0.72

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	600.82M	388.24M	531.95M	644.62M	702.64M	744.15M	783.62M	812.50M
Revenue Growth	-10.08%	-35.38%	37.02%	21.18%	9.00%	5.91%	5.30%	3.69%
EPS	0.67	-0.52	-0.34	0.06	0.54	0.72	0.79	0.82
EPS Growth	81.76%	-	-	-	807.61%	33.30%	9.31%	4.35%
Forward PE	-	-	-	-	-	25.38	23.22	22.25
No. Analysts	-	-	-	-	-	9	9	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	792.7M	843.5M	901.7M
Avg	744.2M	783.6M	812.5M
Low	692.3M	716.3M	734.5M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	12.8%	13.3%	15.1%
Avg	5.9%	5.3%	3.7%
Low	-1.5%	-3.7%	-6.3%

EPS Forecast

EPS	2025	2026	2027
High	0.80	0.88	0.86
Avg	0.72	0.79	0.82
Low	0.67	0.73	0.77

EPS Growth

EPS Growth	2025	2026	2027
High	47.8%	22.5%	9.4%
Avg	33.3%	9.3%	4.4%
Low	23.4%	0.7%	-1.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.